HUB Organoids extends partnership with Molecular Devices to advance automated intestinal organoid screening technology

Featured Story

HUB Organoids extends partnership with Molecular Devices to advance automated intestinal organoid screening technology

SAN JOSE, Calif., and UTRECHT, Netherlands, Feb. 13, 2023 – Molecular Devices, LLC., a leading provider of high-performance life science...

Read More

More from HUB

HUB Organoids take their first parabolic flight!

HUB Organoids take their first parabolic flight!

FDA Modernization Act 2.0: We welcome the dawn of an organoid era

FDA Modernization Act 2.0: We welcome the dawn of an organoid era

Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows how

Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows how

Patients with mutated KRAS (Kirsten rat sarcoma virus) gene account for around 30-50% of the population with colorectal cancer (CRC)...

X

Have any questions?

contact us